Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients

Table 5 Effect modification by having hyperuricemia of the associations in the main model

Variable	Having hyperuricemia
	Odds ratio	95%CI	P value
Age (years)	1.06	1.03–1.09	< 0.01
Receiving hyperuricemia treatment	2.45	1.31–4.59	< 0.01
Having previous cardiovascular events	41.70	13.62–127.64	< 0.01
Having left ventricular hypertrophy	15.33	2.02–116.60	< 0.01
Having anemia	5.36	2.75–10.48	< 0.01